These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
496 related articles for article (PubMed ID: 19733654)
21. Osthol ameliorates fat milk-induced fatty liver in mice by regulation of hepatic sterol regulatory element-binding protein-1c/2-mediated target gene expression. Du R; Xue J; Wang HB; Zhang Y; Xie ML Eur J Pharmacol; 2011 Sep; 666(1-3):183-8. PubMed ID: 21620823 [TBL] [Abstract][Full Text] [Related]
22. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089 [TBL] [Abstract][Full Text] [Related]
23. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105 [TBL] [Abstract][Full Text] [Related]
24. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Sekiya M; Yahagi N; Matsuzaka T; Najima Y; Nakakuki M; Nagai R; Ishibashi S; Osuga J; Yamada N; Shimano H Hepatology; 2003 Dec; 38(6):1529-39. PubMed ID: 14647064 [TBL] [Abstract][Full Text] [Related]
25. Reversion of steatosis by SREBP-1c antisense oligonucleotide did not improve hepatic insulin action in diet-induced obesity mice. Vitto MF; Luz G; Luciano TF; Marques SO; Souza DR; Pinho RA; Lira FS; Cintra DE; De Souza CT Horm Metab Res; 2012 Nov; 44(12):885-90. PubMed ID: 22932913 [TBL] [Abstract][Full Text] [Related]
26. Beneficial effects of mangiferin on hyperlipidemia in high-fat-fed hamsters. Guo F; Huang C; Liao X; Wang Y; He Y; Feng R; Li Y; Sun C Mol Nutr Food Res; 2011 Dec; 55(12):1809-18. PubMed ID: 22038976 [TBL] [Abstract][Full Text] [Related]
27. Molecular effects of ER alpha- and beta-selective agonists on regulation of energy homeostasis in obese female Wistar rats. Weigt C; Hertrampf T; Kluxen FM; Flenker U; Hülsemann F; Fritzemeier KH; Diel P Mol Cell Endocrinol; 2013 Sep; 377(1-2):147-58. PubMed ID: 23871901 [TBL] [Abstract][Full Text] [Related]
28. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet. Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065 [TBL] [Abstract][Full Text] [Related]
29. Altered hepatic expression of SREBP-1 and PPARgamma is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients. Lemoine M; Barbu V; Girard PM; Kim M; Bastard JP; Wendum D; Paye F; Housset C; Capeau J; Serfaty L AIDS; 2006 Feb; 20(3):387-95. PubMed ID: 16439872 [TBL] [Abstract][Full Text] [Related]
30. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α. Ren T; Zhu J; Zhu L; Cheng M Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264426 [TBL] [Abstract][Full Text] [Related]
31. Hibiscus sabdariffa L. aqueous extract attenuates hepatic steatosis through down-regulation of PPAR-γ and SREBP-1c in diet-induced obese mice. Villalpando-Arteaga EV; Mendieta-Condado E; Esquivel-Solís H; Canales-Aguirre AA; Gálvez-Gastélum FJ; Mateos-Díaz JC; Rodríguez-González JA; Márquez-Aguirre AL Food Funct; 2013 Apr; 4(4):618-26. PubMed ID: 23389749 [TBL] [Abstract][Full Text] [Related]
32. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Enjoji M; Takayanagi R; Nakamuta M Int J Mol Med; 2008 Apr; 21(4):507-11. PubMed ID: 18360697 [TBL] [Abstract][Full Text] [Related]
33. RETRACTED: Reversion of hepatic steatosis by exercise training in obese mice: the role of sterol regulatory element-binding protein-1c. Cintra DE; Ropelle ER; Vitto MF; Luciano TF; Souza DR; Engelmann J; Marques SO; Lira FS; de Pinho RA; Pauli JR; De Souza CT Life Sci; 2012 Oct; 91(11-12):395-401. PubMed ID: 22906631 [TBL] [Abstract][Full Text] [Related]
34. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Ferré P; Foufelle F Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():83-92. PubMed ID: 21029304 [TBL] [Abstract][Full Text] [Related]
35. Differential expression of lipid metabolism genes in the liver and adipose tissue of mice treated with evodiamine. Jiang DF; Zhang XG; Yang HL; Sun C Genet Mol Res; 2013 May; 12(2):1501-10. PubMed ID: 23315872 [TBL] [Abstract][Full Text] [Related]
36. Iron-induced pro-oxidant and pro-lipogenic responses in relation to impaired synthesis and accretion of long-chain polyunsaturated fatty acids in rat hepatic and extrahepatic tissues. Valenzuela R; Rincón-Cervera MÁ; Echeverría F; Barrera C; Espinosa A; Hernández-Rodas MC; Ortiz M; Valenzuela A; Videla LA Nutrition; 2018 Jan; 45():49-58. PubMed ID: 29129237 [TBL] [Abstract][Full Text] [Related]
37. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. Kammoun HL; Chabanon H; Hainault I; Luquet S; Magnan C; Koike T; Ferré P; Foufelle F J Clin Invest; 2009 May; 119(5):1201-15. PubMed ID: 19363290 [TBL] [Abstract][Full Text] [Related]
38. Influences of sterol regulatory element binding protein-1c silencing on glucose production in HepG2 cells treated with free fatty acid. Bai XP; Dong F; Yang GH; Zhang L Lipids Health Dis; 2019 Apr; 18(1):89. PubMed ID: 30954075 [TBL] [Abstract][Full Text] [Related]
39. Decreased liver fatty acid delta-6 and delta-5 desaturase activity in obese patients. Araya J; Rodrigo R; Pettinelli P; Araya AV; Poniachik J; Videla LA Obesity (Silver Spring); 2010 Jul; 18(7):1460-3. PubMed ID: 19875987 [TBL] [Abstract][Full Text] [Related]
40. [Effect of soothing liver and invigorating spleen recipes on SREBP-1c mRNA and protein expression in hepatic tissues of rats with non-alcoholic fatty liver disease]. He XM; Yang QH; Li PF; Chen Z; Feng GF; Wang WJ; Liu HT; Zhang YP; Ji GY Zhong Yao Cai; 2011 Jun; 34(6):931-7. PubMed ID: 22017010 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]